Mathematically modelling and controlling prostate cancer under intermittent hormone therapy

Area of Science:

• Oncology
• Mathematical Biology
• Pharmacology

Background:

• Hormone therapy is effective for prostate cancer (PCa) initially but often leads to resistance.
• Intermittent androgen suppression (IAS) is an alternative strategy to circumvent hormone resistance.
• Current IAS protocols lack patient-specific optimal scheduling, leading to variable clinical effectiveness.

Purpose of the Study:

• To develop mathematical models for predicting PCa response to IAS.
• To elucidate the mechanisms underlying IAS effectiveness and resistance.
• To provide an optimized treatment schedule for IAS.

Main Methods:

• Development of novel mathematical models for PCa dynamics under IAS.
• Analysis of model outputs to understand treatment effects and resistance development.
• Simulation of various IAS schedules to identify optimal treatment parameters.

Main Results:

• The developed models accurately predict the effects of IAS on PCa growth and relapse.
• Mathematical modeling explains how IAS can overcome or delay hormone resistance.
• Optimal on- and off-treatment cycles were identified for IAS based on model simulations.

Conclusions:

• Mathematical modeling offers a powerful tool for understanding and optimizing IAS for PCa.
• IAS can be an effective strategy for managing PCa, particularly when treatment schedules are personalized.
• Further research and clinical validation of these models are warranted to refine IAS protocols.